文献速递血栓与止血

ACTN1突变导致良性血小板大细胞症,不总伴血小板减少

ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia.
PubMed 文献 · Br J Haematol · 2018-10-23

本文报告7个新的ACTN1相关血小板减少症(ACTN1-RT)家系,其中2个为新错义变异(p.Trp128Cys和p.Pro233Leu),体外研究证实其致病性。结合既往10个家系,共49例ACTN1突变携带者,为迄今最大病例系列。结论:ACTN1-RT是全球第四常见的遗传性血小板减少症,所有受累者均有血小板大细胞症,不足80%有轻度血小板减少,出血风险可忽略,无其他先天或获得性缺陷,为良性形式,诊断可提供良好预后。

要点

  • ACTN1-RT为良性遗传性血小板减少症,所有受累者均有血小板大细胞症。
  • 不足80%的病例出现轻度血小板减少,出血风险可忽略。
  • 无其他先天或获得性缺陷,诊断可提供良好预后。

核心结论

  • ACTN1-RT是全球第四常见的遗传性血小板减少症,为良性形式,诊断可提供良好预后。

研究设计与样本

  • 研究纳入7个新发无关ACTN1-RT家系,其中2个为新错义变异(p.Trp128Cys和p.Pro233Leu),体外研究证实致病性;结合既往10个家系,共49例ACTN1突变携带者,为迄今最大病例系列。

主要发现

  • 所有受累者均表现为血小板大细胞症。
  • 不足80%的病例出现轻度血小板减少。
  • 自发性或止血挑战后出血风险可忽略。
  • 无其他先天或获得性缺陷。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The inherited thrombocytopenias (IT) are a heterogeneous group of diseases resulting from mutations in more than 30 different genes. Among them, ACTN1-related thrombocytopenia (ACTN1-RT; Online Mendelian Inheritance in Man: 615193) is one of the most recently identified forms. It has been described as a mild autosomal dominant macrothrombocytopenia caused by mutations in ACTN1, a gene encoding for one of the two non-muscle isoforms of α-actinin. We recently identified seven new unrelated families with ACTN1-RT caused by different mutations. Two of them are novel missense variants (p.Trp128Cys and p.Pro233Leu), whose pathogenic role has been confirmed by in vitro studies. Together with the 10 families we have previously described, our cohort of ACTN1-RT now consists of 49 individuals carrying ACTN1 mutations. This is the largest case series ever collected and enabled a critical evaluation of the clinical aspects of the disease. We concluded that ACTN1-RT is the fourth most frequent form of IT worldwide and it is characterized by platelet macrocytosis in all affected subjects and mild thrombocytopenia in less than 80% of cases. The risk of bleeding, either spontaneous or upon haemostatic challenge, is negligible and there are no other associated defects, either congenital or acquired. Therefore, ACTN1-RT is a benign form of IT, whose diagnosis provides affected individuals and their families with a good prognosis.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Faleschini M, Melazzini F, Marconi C, et al. ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia. Br J Haematol. 2018. PMID: 30351444. doi:10.1111/bjh.15531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。